1 Medical Intensive Care Unit, Grenoble Alpes University Hospital, Grenoble, France.
2 HP2 Laboratory, INSERM 1300, Grenoble Alpes University, Grenoble, France.
3 Department of Biostatistics, OutcomeRea, Paris, France.
4 Medical Unit, French and British Institute, Levallois-Perret, France.
5 Intensive Care Unit, Avicenne Hospital, AP-HP, Paris, France.
6 Medical Intensive Care Unit, Meaux Hospital, Meaux, France.
7 Medical Intensive Care Unit, La Timone Hospital, Marseille, France.
8 Critical Care Medicine Unit, Etampes-Dourdan Hospital, Etampes, France.
9 Medical Intensive Care Unit, Gabriel Montpied University Hospital, Clermont-Ferrand, France.
10 Intensive Care Unit, AP-HP, Saint-Louis Hospital, Paris, France.
11 Medical Intensive Care Unit, Nord University Hospital, Marseille, France.
12 Polyvalent Intensive Care Unit, Delafontaine Hospital, Saint-Denis, France.
13 Medical Intensive Care Unit, Le Raincy-Montfermeil Hospital, Montfermeil, France.
14 Intensive Care Unit, André Mignot Hospital, Le Chesnay, France.
15 Medical and Infectious diseases Intensive Care Unit (MI2), Bichat Hospital, AP-HP, Paris, France.
16 Infection, Antimicrobials, Modelling, Evolution laboratory, UMR 1137, University of Paris, Paris, France.
17 Medical Intensive Care Unit, Edouard Herriot Hospital, Lyon Civil Hospices, Lyon, France.
18 Medical Intensive Care Unit, Nantes University Hospital, Nantes, France.
All authors were involved in acquisition of clinical data and patient’s diagnosis and treatment, and final approval of the article. Drs. Galerneau, Bailly, Terzi, Ruckly, Pepin, and Timsit were involved in interpretation of data and drafting the article. Drs. Galerneau, Terzi, Pepin, and Timsit were involved in design of the presented idea and drafting the article. Drs. Galerneau, Bailly, Terzi, Ruckly, Pepin, and Timsit were involved in interpretation of data. Drs. Galerneau and Bailly were involved in performed statistical analysis. Drs. Galerneau, Bailly, Ruckly, and Timsit were involved in data management. The article was written on behalf of the OUTCOMEREA Network listed in the Appendix (https://links.lww.com/CCM/H290).
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Drs. Bailly and Pepin are supported by the French National Research Agency in the framework of the “Investissements d’avenir” program (ANR-15-IDEX-02) and Grenoble Alpes University Foundation Chairs of excellence: “e-health and integrated care and trajectories medicine and Multidisciplinary Institute in Artificial Intelligence) (MIAI) artificial intelligence” This work has been partially supported by MIAI @ Grenoble Alpes (ANR-19-P3IA-0003).
Dr. Terzi received funding from Pfizer for attending meetings and/or travel. Dr. Hong Tuan Ha disclosed work for hire. The remaining authors have disclosed that they do not have any potential conflicts of interest.
The members of the OUTCOMEREA study group are listed in the Appendix (https://links.lww.com/CCM/H290).
For information regarding this article, E-mail: [email protected]
